Author:
Clarke Michael,Wong Gar-Yun,Hogg Jeffry
Publisher
Springer International Publishing
Reference258 articles.
1. Judge DP, Dietz HC. Marfan’s syndrome. Lancet. 2005;366(9501):1965–76.
2. Godfrey M, Menashe V, Weleber RG, Koler RD, Bigley RH, Lovrien E, et al. Cosegregation of elastin-associated microfibrillar abnormalities with the Marfan phenotype in families. Am J Hum Genet. 1990;46(4):652–60.
3. Cook JR, Ramirez F. Clinical, diagnostic, and therapeutic aspects of the Marfan syndrome. Adv Exp Med Biol. 2014;802:77–94.
4. Benke K, Ágg B, Szilveszter B, Tarr F, Nagy ZB, Pólos M, et al. The role of transforming growth factor-beta in Marfan syndrome. Cardiol J. 2013;20(3):227–34.
5. Quarto N, Li S, Renda A, Longaker MT. Exogenous activation of BMP-2 signaling overcomes TGFbeta-mediated inhibition of osteogenesis in Marfan embryonic stem cells and Marfan patient-specific induced pluripotent stem cells. Stem Cells. 2012;30(12):2709–19.